Prostate Cancer Clinical Trial
Official title:
2013 Annual National Digital Rectal Exam (DRE) Day: Impact on Prostate Health Awareness and Disease Detection
We aim to determine the effectiveness of 2013 "Mag paDRE ka" programme in increasing general public awareness on prostate health and promoting prostate health assessment among Filipino males aged 40 or older.
Convenience sampling method will be applied to collect all completed Philippine Urological
Association (PUA) survey forms from the 11 Philippine Board of Urology accredited training
institutions. A data collection form for the purpose of this study will be used to extract
data from the Philippine Urological Association survey forms. The data collection form for
this study will extract data, which include basic demographic characteristics of the
patients (such as age and educational attainment), family history of prostate cancer, other
medical conditions, history of prior prostate screening/ consultation for Lower urinary
tract Symptoms or prostate disease. The International Prostate Symptom scores (IPSS)
collected will be stratified according to mild (1-7), moderate (8-19) and severe (20-35) and
the Filipino version Quality of Life (QoL) ratings will be stratified according to Grade 1,
grade 2 and grade 3. DRE findings including the approximation of prostate size and prostate
characteristic findings will be clustered to normal in size (20grams or less) versus
enlarged (>20grams or 2 fingerbreadths in width), nodular vs non-nodular, doughy or hard,
and tender versus non-tender.
Participants will be classified according to the following :
1. Target population for screening or not :
Target population for screening is defined as Filipino males aged 40 years or older,
who also had no previous consultation for Lower urinary tract symptoms (LUTS) or
prostate cancer screening in the past 12 months
2. Case Finding for significant LUTS or prostate cancer or not :
Case of LUTS or prostate cancer is defined as Filipino males aged 40 years or older with
IPSS > 8, OR, has abnormal Digital rectal exam (DRE) finding, which is defined as nodular OR
hard OR tender. However, DRE finding of an enlarged prostate but non-nodular, doughy in
character and non-tender will not be considered as a case of LUTS or prostate cancer
suspect).
Confidentiality of all data will be assured. The case report forms/ data collection form for
this study will not contain any patient identifiers. All patient records will be coded in
the electronic database as serial number and PUA-designated Institutional code (i.e. SLMC
#0001). Only the investigators of this study and other authorized personnel from PUA will be
given access to the study data. The PUA survey forms will be secured, filed and only
accessed in PUA secretariat building. The electronic database coded with the data from the
data collection from of this study will be set with password, and only the study
investigators have access to the password.
;
Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |